Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
N

Neuromeka Co Ltd
KOSDAQ:348340

Watchlist Manager
Neuromeka Co Ltd
KOSDAQ:348340
Watchlist
Price: 83 000 KRW 2.09% Market Closed
Market Cap: ₩943.7B
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

Price Targets Summary
Neuromeka Co Ltd

Wall Street analysts forecast Neuromeka Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Neuromeka Co Ltd is 31 620 KRW with a low forecast of 31 310 KRW and a high forecast of 32 550 KRW.

Lowest Forecast
Wall Street Target
31 310 KRW
-62% Downside
Average Forecast
Wall Street Target
31 620 KRW
-62% Downside
Highest Forecast
Wall Street Target
32 550 KRW
-61% Downside
Lowest
Price Target
31 310 KRW
62% Downside
Average
Price Target
31 620 KRW
62% Downside
Highest
Price Target
32 550 KRW
61% Downside
Neuromeka Co Ltd Competitors:
Price Targets

Revenue
Forecast

58% / Year
Past Growth
36% / Year
Estimated Growth
Estimates Accuracy
-24%
Average Miss
58% / Year
Past Growth
36% / Year
Estimated Growth
Estimates Accuracy
-24%
Average Miss

For the last 4 years the compound annual growth rate for Neuromeka Co Ltd's revenue is 58%. The projected CAGR for the next 3 years is 36%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Neuromeka Co Ltd's stock price target?
Price Target
31 620 KRW

According to Wall Street analysts, the average 1-year price target for Neuromeka Co Ltd is 31 620 KRW with a low forecast of 31 310 KRW and a high forecast of 32 550 KRW.

What is Neuromeka Co Ltd's Revenue forecast?
Projected CAGR
36%

For the last 4 years the compound annual growth rate for Neuromeka Co Ltd's revenue is 58%. The projected CAGR for the next 3 years is 36%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 317,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.